AIM Immunotech Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by AIM Immunotech Inc. on April 4, 2025. The Company is incorporated in Delaware and its common stock (Symbol: AIM) was previously listed on the NYSE American. The filing addresses a critical corporate event regarding the Company's listing status.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on regulatory and listing status updates.
Material Changes
- Delisting Notice: On April 4, 2025, the Company received notice from NYSE Regulation that trading of its common stock was suspended.
- Reason for Delisting: The NYSE American determined the Company is no longer suitable for listing under Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of its common stock.
- Trading Venue Change: The Company's common stock is expected to begin trading on the Pink Open Market on April 7, 2025.
Outlook, Risks, and Management Commentary
- Appeal Process: The Company has the right to appeal the delisting determination to the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the NYSE American. However, the filing states there can be no assurance that such an appeal will be successful.
- Forward-Looking Statements: The filing includes statements regarding the Company's intention to regain compliance with NYSE American listing requirements. Management warns that actual results may differ materially from these expectations due to various risks and uncertainties.
- Risk Factors: Investors are directed to review risk factors in the Company's most recent Form 10-K and subsequent filings.
Key Facts for Investor Verification
- Confirm the exact date trading resumes on the Pink Open Market (expected April 7, 2025).
- Monitor the status of the Company's appeal to the NYSE American Listings Qualifications Panel.
- Review the Company's most recent Form 10-K for detailed financial health and risk factors not included in this 8-K.
- Verify the current share price and liquidity on the Pink Open Market once trading commences.